Jeffrey Greve

Company: Kyverna Therapeutics

Job title: CSO

Seminars:

Developing synReg T Cells: Synthetic Tregs Targeted to Disease Tissues & Cells to Provide Transformative Treatments For Autoimmune Diseases 11:30 am

Creating synthetic Tregs by reprogramming CD4 T cells Sharing cell engineering strategies to direct synthetic Tregs to home to disease tissues and cells Developing a robust synReg manufacturing processRead more

day: Day two track 1 AM